Apimeds Pharmaceuticals US, Inc.

Market Cap

$2M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NYSE MKT

Healthcare·Drug·🇺🇸·NYSE MKT

Stock Price

$0.86-$0.81 (-48.35%)

Jul 6, 2026

52W High $3.9052W Low $0.86

Company Details

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of In...

Leadership

Erik C. Emerson

President

Erick J. Frim

Chief Financial Officer

Vinod MenonFounder

Founder & Co-CEO

Sungjoon Chae

Co-Chief Executive Officer

Captain Sandeep Singh Yadav

Chief Operating Officer

Amardeep Singh

Chief Technology Officer

IPO Date

May 9, 2025

Website

www.mindwavedao.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$5M

EPS (Diluted)

Free Cash Flow

-$5M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee